N4-Hydroxycytidine

SKU: orb1298882

Featured

Description

EIDD-1931 is a ribonucleoside analog exhibiting broad-spectrum antiviral activity against betacoronaviruses, including SARS-CoV, MERS-CoV, and SARS-CoV-2, with low micromolar IC50 values in vitro. Its research applications extend to studying viral replication mechanisms and evaluating antiviral efficacy in both cellular and animal models of coronavirus infection.

Research Area

Pharmacology & Drug Discovery

Images & Validation

−

Key Properties

−

CAS Number	3258-02-4
MW	259.2
Purity	>98%
Formula	C₉H₁₃N₃O₆
SMILES	OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cc\c(=N/O)[nH]c1=O
Target	Virus Protease,SARS-CoV,HCV Protease,Topoisomerase
Solubility	Soluble in DMSO (up to 25 mg/ml) or in Water (up to 15 mg/ml with warming).

Storage & Handling

−

Storage	-20°C
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

beta-D-N4-hydroxycytidine; EIDD-1931

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Compound Identifiers

PubChem CID

197020 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols